Innovative Diagnostic Laboratory LLP sales and marketing update

Innovative Diagnostic launched the ColonSentry blood test in the U.S. to assess a patient's risk for colorectal cancer.

Read the full 180 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE